Articles related to ATRIAL FIBRILLATION (AFIB)

In the complex landscape of post-cardiac surgery care, the incidence of new-onset PCSAF presents a significant challenge, necessitating a judicious approach to anticoagulation to prevent thromboembolic events while minimizing bleeding risks.

This study underscores the critical need for precise diagnostic criteria in treating unexplained strokes and the potential reevaluation of anticoagulant use in patients with atrial cardiopathy, opening new avenues for research and patient care.

In the landscape of cardiac monitoring, consumer-grade smart devices have shown a remarkable ability to detect atrial fibrillation with high sensitivity and specificity, challenging the traditional reliance on medical-grade monitoring tools.

In this pivotal trial, apixaban, when used for subclinical atrial fibrillation, demonstrated a 0.63 hazard ratio for stroke or systemic embolism compared to aspirin, indicating a significant reduction in stroke risk at the expense of increased bleeding risk.

The study underscores the potential of user-owned devices in health monitoring. With a positive predictive value of 0.84, the smartwatch app could be a significant step towards large-scale, user-driven monitoring for atrial fibrillation.

Discover how catheter ablation combined with medical therapy can improve outcomes for atrial fibrillation patients with end-stage heart failure.